+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transdermal nicotine use in postmenopausal women: Does the treatment efficacy differ in women using and not using hormone replacement therapy?



Transdermal nicotine use in postmenopausal women: Does the treatment efficacy differ in women using and not using hormone replacement therapy?



Nicotine & Tobacco Research 6(5): 777-788




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 063326296

Download citation: RISBibTeXText

DOI: 10.1080/1462220042000274239


Related references

Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?. Nicotine and Tobacco Research 6(5): 777-788, 2004

Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women. Maturitas 37(2): 83-93, 2000

Efficacy and tolerability of fully transdermal hormone replacement in sequential or continuous therapy at two doses of progestogen in postmenopausal women. Maturitas 37(2): 83-93, 2000

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. Journal of Internal Medicine 238(1): 39-47, 1995

Efficacy of treatment with combined hormone replacement therapy for hyperlipidemia among postmenopausal women. Circulation 90(4 Part 2): I363, 1994

Transdermal Hormone Replacement Therapy in Postmenopausal Women With Uterine Leiomyomas. Obstetrics & Gynecology 98(6): 1053-1058, 2001

Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstetrics & Gynecology 98(6): 1053-1058, 2001

Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstetrics and Gynecology 98(6): 1053-1058, 2001

Hormone replacement therapy does not prevent coronary heart disease and is associated with increased overall risk for health of postmenopausal women. Final results of studies on hormone replacement therapy efficacy in frame of Women's Health Initiative and data from other recent studies. Kardiologiia 43(9): 77-79, 2003

Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 7(1): 36-41, 2000

Urinary cGMP excretion after oral and transdermal hormone replacement therapy in postmenopausal women. European Journal of Clinical Pharmacology 52(Suppl. ): A82, 1997

Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?. Breast 20(5): 448-454, 2011

Insulin resistance and short-term transdermal hormone replacement therapy in hypertensive postmenopausal women. Journal of Hypertension 18(Suppl 4): S133, 2000

Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. European Journal of Medical Research 5(2): 63-66, 2000

Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women. Fertility & Sterility 77(3): 476-480, 2002